|Videos|November 4, 2021

Controlling ACE and ARB Dosing Can Benefit Treatment of Chronic Kidney Disease

Chi Chu, MD, an assistant professor in the division of nephrology at the University of California San Francisco, discusses how ACE and ARB therapies can be applied to chronic kidney disease, and the benefits of controlling the dosage.

In a Pharmacy Times® interview, Chi Chu, MD, an assistant professor in the division of nephrology at the University of California San Francisco, spoke about his 2021 ASN Kidney Week presentation on the submaximal dose of angiotensin converting enzyme (ACE) inhibitor and angiotensin II receptor blockers (ARB) for individuals with proteinuria.

He discussed how ACE and ARB therapies can be applied to chronic kidney disease, and the benefits of controlling the dosage.

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!

New Teclistamab Study in Multiple Myeloma Shows Improved Tolerance, Responses
September 18th 2025
Effectively Managing Immunizations in the Long-Term Care Setting
September 18th 2025
Creating a Culture of Quality in Fast-Melt Tablet Development
September 18th 2025
Elranatamab Plus Daratumumab and Lenalidomide Yields Durable Responses, Manageable Safety
September 18th 2025
Triazole Antifungal Therapy: The Clinical Utilization of Therapeutic Drug Monitoring
September 18th 2025
High Glucose Levels Associated With Worse Outcomes After Acute Myocardial Infarction
September 18th 2025

Latest CME

Virtual Conference

Directions in Oncology Pharmacy® 2025: Midwest

Saturday, September 20, 2025

On-Demand Webinar

BURST Expert Illustrations and Commentaries™: Exploring the Mechanistic Rationale for CSF-1R– Directed Treatment in Chronic GVHD

1.0 Credit / Hematologic Cancer, Oncology

Virtual Conference

Directions in Oncology Pharmacy® 2025: Southwest

Saturday, October 4, 2025

Webinar Registration

From Testing to Treatment: Empowering Pharmacists to Overcome Barriers and Optimize Biomarker-Driven Care

October 9, 2025 | 1:00 & 8:00 PM EDT

Webinar Registration

Clinical Presentation of Hyperglycemia With PI3K and AKT Inhibitors

October 14, 2025 | 1:00 PM & 8:00 PM ET

Panel Discussion Registration

Multidisciplinary Insights to Enhance Biomarker Testing Practices in Non-Small Cell Lung Cancer

October 15, 2025 | 7:00 PM EDT

Virtual Conference

Directions in Oncology Pharmacy® 2025: West Coast

Thursday, October 16, 2025

Webinar Registration

The Expanding Therapeutic Landscape in IgA Nephropathy: Translating New Clinical Evidence and Updated Guidelines Into Managed Care Strategies

October 21, 2025 | 1:00 PM & 8:00 PM ET

Webinar Registration

Targeting the Root of Autoimmunity in Generalized Myasthenia Gravis: Pharmacist Strategies for Integrating FcRn Therapies Into Specialty Practice

October 23, 2025 | 12:00 PM & 8:00 PM EDT

Webinar Registration

Optimizing Lipid Management in Statin-Intolerant Populations: Payer Strategies for Evidence-Based Access and Risk Reduction

October 23, 2025 | 1:00 PM & 6:00 PM ET

In-Person + Virtual Event

ASCP 2025 Satellite Symposia

October 24-25, 2025

Webinar Registration

Effective Strategies to Manage Hyperglycemia When Treating with PI3K and AKT Inhibitors

October 28, 2025 | 12:00 PM & 7:00 PM EDT

In-Person + Virtual Event

AMCP Nexus 2025

October 28-29, 2025

Panel Discussion Registration

Multidisciplinary Insights and Strategies for Patients Treated With PI3K and AKT Inhibitors to Prevent Hyperglycemia

October 30, 2025 | 7:00 PM EDT

Controlling ACE and ARB Dosing Can Benefit Treatment of Chronic Kidney Disease

Newsletter

Related Articles

Latest CME

Directions in Oncology Pharmacy® 2025: Midwest

BURST Expert Illustrations and Commentaries™: Exploring the Mechanistic Rationale for CSF-1R– Directed Treatment in Chronic GVHD

Directions in Oncology Pharmacy® 2025: Southwest

From Testing to Treatment: Empowering Pharmacists to Overcome Barriers and Optimize Biomarker-Driven Care

Clinical Presentation of Hyperglycemia With PI3K and AKT Inhibitors

Multidisciplinary Insights to Enhance Biomarker Testing Practices in Non-Small Cell Lung Cancer

Directions in Oncology Pharmacy® 2025: West Coast

The Expanding Therapeutic Landscape in IgA Nephropathy: Translating New Clinical Evidence and Updated Guidelines Into Managed Care Strategies

Targeting the Root of Autoimmunity in Generalized Myasthenia Gravis: Pharmacist Strategies for Integrating FcRn Therapies Into Specialty Practice

Optimizing Lipid Management in Statin-Intolerant Populations: Payer Strategies for Evidence-Based Access and Risk Reduction

ASCP 2025 Satellite Symposia

Effective Strategies to Manage Hyperglycemia When Treating with PI3K and AKT Inhibitors

AMCP Nexus 2025

Multidisciplinary Insights and Strategies for Patients Treated With PI3K and AKT Inhibitors to Prevent Hyperglycemia

The Role of Pharmacists in Pneumococcal Prevention: Strategies to Improve Vaccine Uptake

Collaborating Across the Continuum™: Identifying and Preventing Hepatic Encephalopathy in Long-Term Care Settings

Asembia Specialty Pharmacy Day of Education 2025

Closing Gaps in CLL Care: Managed Care Insights and Strategies

Enhancing Safety in Cancer Care: Expert Guidance on Toxicity Management of HER2, TROP2, and HER3-Targeted Antibody-Drug Conjugates

Continuous Glucose Monitoring: What's New in 2025? (Pharmacy Technician)

Beyond the Prescription: Tackling Social Isolation for Better Health

Leveraging Novel Therapies to Transform Demodex Blepharitis Care (Pharmacy Technician Credit)

Leveraging Novel Therapies to Transform Demodex Blepharitis Care

Navigating the Complexity of Migraine: A Multimodal Approach to Acute Treatment

New and Emerging Therapies for the Management of Narcolepsy: A Guide to Patient-Centered Care

Iron Deficiency Anemia Treatment Considerations in Women’s Health

The Changing Paradigm in Pain Management and Supporting Access to Novel Therapies

Personalizing Treatment in Relapsed/Refractory Multiple Myeloma: The Evolving Role of Antibody-Drug Conjugates and Bispecific Antibodies

Adapting to Advances in EGFR-Positive Non-Small Cell Lung Cancer Treatment: Critical Insights for Oncology Pharmacists

Securing the Supply Chain: The Pharmacists’ Role in DSCSA Compliance

Bridging Knowledge Gaps in HR+/HER2– Early-Stage Breast Cancer

Optimizing HER2-Directed Therapy in Metastatic Breast Cancer: From HER2-Positive to HER2-Ultralow

Shaping the Future of Generalized Myasthenia Gravis Management: A Focus on Novel Treatment Approaches

Expert Insights on the Horizon of HER2-Directed Therapy

Breaking Barriers in Asthma Care: Exploring the Role of Type 2 Inflammation and Biologic Therapies

Type 2 Inflammation in Focus: Advancing Pediatric Atopic Dermatitis Care With Biologic Therapies

Updated Guidance and Managed Care Strategies to Optimize Care in EGFR Mutated NSCLC

Payment for Pharmacist Services: 2025 Update

The Oncology Pharmacist's Role in Managing Small Molecule Inhibitor Use in Chronic Lymphocytic Leukemia to Enhance Patient-Centered Care

Redefining Complement-Mediated Kidney Disease: The Latest in Diagnosis and Treatment

Advancing Pharmacist Expertise in R/R FL: Navigating Novel Therapies and Optimizing Patient Outcomes

Paroxysmal Nocturnal Hemoglobinuria: Managed Care Strategies to Mitigate Burden and Enhance Outcomes

Navigating Novel Therapies in Steroid-Refractory cGVHD: Practical Strategies for Community-Based Oncology Pharmacists

Precision Matters: Foundations of Biomarker-Driven Care in Non-Small Cell Lung Cancer

SimulatEd™: Patient-Centered Care to Improve Outcomes in Chronic Lymphocytic Leukemia

From Strict Avoidance to Tailored Therapies: Transforming Food Allergy Care

The Evolving Strategies for Managing nAMD and DME: Empowering Managed Care Decisions for Improved Patient Outcomes

Innovations in Diabetes Technology: A New Era of Patient Choice and Opportunities for Pharmacists to Support Insulin Pump Management

Innovations in Diabetes Technology: A New Era of Patient Choice and Opportunities for Pharmacists to Support Insulin Pump Management (Pharmacy Technician Credit)

Addressing the Unmet Needs in the Management of Myasthenia Gravis: The Role of New and Emerging Therapies

Harnessing the Potential of SGLT2 Inhibitors in Cardiorenal Metabolic Health: Strategies for Long-term Care and Consultant Pharmacists

Transforming Small Cell Lung Cancer Management With DLL3-Targeted Therapies

How Artificial Intelligence Is Transforming Cancer Care: Essential Insights for Oncology Pharmacists

The Role of the Pharmacist Migraine Management

Guiding Bispecific Antibody Use in Non-Hodgkin Lymphoma: Integrating Evidence and Enhancing Care

Emerging Biologic Therapy for the Management of COPD: Integrated Approaches to Optimized Care

Strategies to Reduce Challenges in the Management of Chronic Rhinosinusitis with Nasal Polyps: The Role of Biologic Therapy

Navigating the New Wave in Targeted Therapies for Acute Myeloid Leukemia: A Focus on IDH and FLT3 Mutations

Exploring HIV Long-Acting Injectable Uptake: How Pharmacists Can Encourage Long-Acting Injectables to Stem the Spread of HIV

Optimizing LDL-C Lowering and Adherence to Hyperlipidemia Guidelines

Driving Better Outcomes in Hypertrophic Cardiomyopathy: A Managed Care Imperative

Managed Care Approaches and Models for Equitable Access to Innovations in Major Depressive Disorder Treatment

Updated Guidance and Managed Care Strategies to Optimize Respiratory Syncytial Virus Vaccination Coverage

Advancing Care in Metastatic Prostate Cancer Care: Emerging Combination Therapies and Patient-Centered Strategies

Leveraging Biologics and Immunotherapies in the Management of Food Allergies

Pulmonary Arterial Hypertension: Real-World Applications of New Therapies and Management Strategies

Beyond Chimeric Antigen Receptor T-Cell Therapy: Comprehensive Approaches for Community Oncology Practices in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Improving the Care of Persons Living With Diabetes Using CGM Devices (Pharmacy Technician Credit)

Continuous Glucose Monitoring: What's New in 2025?

Advancing Stroke Prevention: The Pharmacist’s Role in Implementing the 2024 Guidelines

Advances and Innovations in Hypertrophic Cardiomyopathy Management: A Focus on New and Emerging Therapies

Beyond the Prescription: Tackling Social Isolation for Better Health (Pharmacy Technician Credit)

Balancing Pain Management and Opioid Use Disorder: Recognition, Treatment, and Compassionate Communication in Pharmacy Practice

Understanding and Personalizing Chronic Obstructive Pulmonary Disease Diagnosis and Treatment

Advancing Multiple Sclerosis Treatment: Exploring Evolving Therapies and Patient-Centered Approaches

Identifying and Personalizing Iron Deficiency Anemia Treatment in Patients With Cancer